nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—atherosclerosis	0.584	1	CbGaD
Cefotetan—ALB—Rosuvastatin—atherosclerosis	0.199	1	CbGbCtD
Cefotetan—Cholestasis—Niacin—atherosclerosis	0.00293	0.0296	CcSEcCtD
Cefotetan—Cefazolin—PON1—atherosclerosis	0.00226	0.488	CrCbGaD
Cefotetan—Vaginal inflammation—Niacin—atherosclerosis	0.00223	0.0225	CcSEcCtD
Cefotetan—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00215	0.0218	CcSEcCtD
Cefotetan—Vaginal infection—Niacin—atherosclerosis	0.0021	0.0213	CcSEcCtD
Cefotetan—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00208	0.0211	CcSEcCtD
Cefotetan—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00201	0.0204	CcSEcCtD
Cefotetan—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00195	0.0197	CcSEcCtD
Cefotetan—Hepatic function abnormal—Niacin—atherosclerosis	0.00185	0.0187	CcSEcCtD
Cefotetan—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00182	0.0184	CcSEcCtD
Cefotetan—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00176	0.0178	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00169	0.0171	CcSEcCtD
Cefotetan—Eosinophilia—Lovastatin—atherosclerosis	0.00161	0.0163	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00158	0.016	CcSEcCtD
Cefotetan—Eosinophilia—Ezetimibe—atherosclerosis	0.00158	0.016	CcSEcCtD
Cefotetan—Eosinophilia—Simvastatin—atherosclerosis	0.00151	0.0152	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00144	0.0145	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00143	0.0145	CcSEcCtD
Cefotetan—Eosinophilia—Pravastatin—atherosclerosis	0.00136	0.0138	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00134	0.0136	CcSEcCtD
Cefotetan—Erythema multiforme—Lovastatin—atherosclerosis	0.00123	0.0124	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00122	0.0123	CcSEcCtD
Cefotetan—Erythema multiforme—Ezetimibe—atherosclerosis	0.00121	0.0122	CcSEcCtD
Cefotetan—Erythema multiforme—Simvastatin—atherosclerosis	0.00115	0.0116	CcSEcCtD
Cefotetan—Haemoglobin—Niacin—atherosclerosis	0.00112	0.0114	CcSEcCtD
Cefotetan—Haemorrhage—Niacin—atherosclerosis	0.00112	0.0113	CcSEcCtD
Cefotetan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00107	0.0108	CcSEcCtD
Cefotetan—Erythema multiforme—Pravastatin—atherosclerosis	0.00104	0.0105	CcSEcCtD
Cefotetan—Leukopenia—Lovastatin—atherosclerosis	0.00101	0.0103	CcSEcCtD
Cefotetan—Discomfort—Lovastatin—atherosclerosis	0.000953	0.00964	CcSEcCtD
Cefotetan—Leukopenia—Simvastatin—atherosclerosis	0.000949	0.00959	CcSEcCtD
Cefotetan—Discomfort—Ezetimibe—atherosclerosis	0.000935	0.00945	CcSEcCtD
Cefotetan—Anaphylactic shock—Lovastatin—atherosclerosis	0.000925	0.00935	CcSEcCtD
Cefotetan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000907	0.00917	CcSEcCtD
Cefotetan—Thrombocytopenia—Lovastatin—atherosclerosis	0.000905	0.00916	CcSEcCtD
Cefotetan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000892	0.00902	CcSEcCtD
Cefotetan—Discomfort—Simvastatin—atherosclerosis	0.000892	0.00901	CcSEcCtD
Cefotetan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000888	0.00898	CcSEcCtD
Cefotetan—Leukopenia—Niacin—atherosclerosis	0.000871	0.00881	CcSEcCtD
Cefotetan—Urticaria—Rosuvastatin—atherosclerosis	0.000867	0.00877	CcSEcCtD
Cefotetan—Anaphylactic shock—Simvastatin—atherosclerosis	0.000865	0.00875	CcSEcCtD
Cefotetan—Abdominal pain—Rosuvastatin—atherosclerosis	0.000863	0.00872	CcSEcCtD
Cefotetan—Leukopenia—Pravastatin—atherosclerosis	0.000858	0.00867	CcSEcCtD
Cefotetan—Thrombocytopenia—Simvastatin—atherosclerosis	0.000847	0.00856	CcSEcCtD
Cefotetan—Discomfort—Pravastatin—atherosclerosis	0.000806	0.00815	CcSEcCtD
Cefotetan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000804	0.00813	CcSEcCtD
Cefotetan—Anaphylactic shock—Niacin—atherosclerosis	0.000794	0.00803	CcSEcCtD
Cefotetan—Anaphylactic shock—Pravastatin—atherosclerosis	0.000782	0.00791	CcSEcCtD
Cefotetan—Pruritus—Rosuvastatin—atherosclerosis	0.000772	0.00781	CcSEcCtD
Cefotetan—Thrombocytopenia—Pravastatin—atherosclerosis	0.000766	0.00774	CcSEcCtD
Cefotetan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000756	0.00765	CcSEcCtD
Cefotetan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000747	0.00755	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000742	0.0075	CcSEcCtD
Cefotetan—Urticaria—Lovastatin—atherosclerosis	0.000735	0.00743	CcSEcCtD
Cefotetan—Abdominal pain—Lovastatin—atherosclerosis	0.000731	0.00739	CcSEcCtD
Cefotetan—Body temperature increased—Lovastatin—atherosclerosis	0.000731	0.00739	CcSEcCtD
Cefotetan—Urticaria—Ezetimibe—atherosclerosis	0.000721	0.00729	CcSEcCtD
Cefotetan—Body temperature increased—Ezetimibe—atherosclerosis	0.000717	0.00725	CcSEcCtD
Cefotetan—Abdominal pain—Ezetimibe—atherosclerosis	0.000717	0.00725	CcSEcCtD
Cefotetan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000707	0.00715	CcSEcCtD
Cefotetan—Rash—Rosuvastatin—atherosclerosis	0.000688	0.00696	CcSEcCtD
Cefotetan—Dermatitis—Rosuvastatin—atherosclerosis	0.000687	0.00695	CcSEcCtD
Cefotetan—Urticaria—Simvastatin—atherosclerosis	0.000687	0.00695	CcSEcCtD
Cefotetan—Abdominal pain—Simvastatin—atherosclerosis	0.000684	0.00691	CcSEcCtD
Cefotetan—Body temperature increased—Simvastatin—atherosclerosis	0.000684	0.00691	CcSEcCtD
Cefotetan—Hypersensitivity—Lovastatin—atherosclerosis	0.000681	0.00689	CcSEcCtD
Cefotetan—Hypersensitivity—Ezetimibe—atherosclerosis	0.000668	0.00676	CcSEcCtD
Cefotetan—Pruritus—Lovastatin—atherosclerosis	0.000654	0.00662	CcSEcCtD
Cefotetan—Gastrointestinal pain—Niacin—atherosclerosis	0.000649	0.00657	CcSEcCtD
Cefotetan—Nausea—Rosuvastatin—atherosclerosis	0.000648	0.00655	CcSEcCtD
Cefotetan—Pruritus—Ezetimibe—atherosclerosis	0.000642	0.00649	CcSEcCtD
Cefotetan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000639	0.00647	CcSEcCtD
Cefotetan—Hypersensitivity—Simvastatin—atherosclerosis	0.000637	0.00644	CcSEcCtD
Cefotetan—Diarrhoea—Lovastatin—atherosclerosis	0.000633	0.0064	CcSEcCtD
Cefotetan—Urticaria—Niacin—atherosclerosis	0.000631	0.00638	CcSEcCtD
Cefotetan—Body temperature increased—Niacin—atherosclerosis	0.000628	0.00635	CcSEcCtD
Cefotetan—Abdominal pain—Niacin—atherosclerosis	0.000628	0.00635	CcSEcCtD
Cefotetan—Urticaria—Pravastatin—atherosclerosis	0.000621	0.00628	CcSEcCtD
Cefotetan—Diarrhoea—Ezetimibe—atherosclerosis	0.000621	0.00628	CcSEcCtD
Cefotetan—Abdominal pain—Pravastatin—atherosclerosis	0.000618	0.00625	CcSEcCtD
Cefotetan—Body temperature increased—Pravastatin—atherosclerosis	0.000618	0.00625	CcSEcCtD
Cefotetan—Pruritus—Simvastatin—atherosclerosis	0.000612	0.00619	CcSEcCtD
Cefotetan—Cefpiramide—ALB—atherosclerosis	0.000597	0.129	CrCbGaD
Cefotetan—Diarrhoea—Simvastatin—atherosclerosis	0.000592	0.00598	CcSEcCtD
Cefotetan—Vomiting—Lovastatin—atherosclerosis	0.000588	0.00595	CcSEcCtD
Cefotetan—Hypersensitivity—Niacin—atherosclerosis	0.000585	0.00592	CcSEcCtD
Cefotetan—Rash—Lovastatin—atherosclerosis	0.000583	0.0059	CcSEcCtD
Cefotetan—Dermatitis—Lovastatin—atherosclerosis	0.000583	0.00589	CcSEcCtD
Cefotetan—Vomiting—Ezetimibe—atherosclerosis	0.000577	0.00583	CcSEcCtD
Cefotetan—Hypersensitivity—Pravastatin—atherosclerosis	0.000576	0.00583	CcSEcCtD
Cefotetan—Rash—Ezetimibe—atherosclerosis	0.000572	0.00578	CcSEcCtD
Cefotetan—Dermatitis—Ezetimibe—atherosclerosis	0.000571	0.00578	CcSEcCtD
Cefotetan—Pruritus—Niacin—atherosclerosis	0.000562	0.00568	CcSEcCtD
Cefotetan—Pruritus—Pravastatin—atherosclerosis	0.000553	0.00559	CcSEcCtD
Cefotetan—Vomiting—Simvastatin—atherosclerosis	0.00055	0.00556	CcSEcCtD
Cefotetan—Nausea—Lovastatin—atherosclerosis	0.000549	0.00555	CcSEcCtD
Cefotetan—Rash—Simvastatin—atherosclerosis	0.000545	0.00551	CcSEcCtD
Cefotetan—Dermatitis—Simvastatin—atherosclerosis	0.000545	0.00551	CcSEcCtD
Cefotetan—Diarrhoea—Niacin—atherosclerosis	0.000543	0.00549	CcSEcCtD
Cefotetan—Nausea—Ezetimibe—atherosclerosis	0.000539	0.00545	CcSEcCtD
Cefotetan—Diarrhoea—Pravastatin—atherosclerosis	0.000535	0.00541	CcSEcCtD
Cefotetan—Cefonicid—ALB—atherosclerosis	0.00052	0.112	CrCbGaD
Cefotetan—Nausea—Simvastatin—atherosclerosis	0.000514	0.0052	CcSEcCtD
Cefotetan—Vomiting—Niacin—atherosclerosis	0.000505	0.00511	CcSEcCtD
Cefotetan—Rash—Niacin—atherosclerosis	0.000501	0.00506	CcSEcCtD
Cefotetan—Dermatitis—Niacin—atherosclerosis	0.0005	0.00506	CcSEcCtD
Cefotetan—Vomiting—Pravastatin—atherosclerosis	0.000497	0.00503	CcSEcCtD
Cefotetan—Rash—Pravastatin—atherosclerosis	0.000493	0.00499	CcSEcCtD
Cefotetan—Dermatitis—Pravastatin—atherosclerosis	0.000493	0.00498	CcSEcCtD
Cefotetan—Nausea—Niacin—atherosclerosis	0.000472	0.00477	CcSEcCtD
Cefotetan—Nausea—Pravastatin—atherosclerosis	0.000465	0.0047	CcSEcCtD
Cefotetan—Cefmetazole—ALB—atherosclerosis	0.000458	0.0988	CrCbGaD
Cefotetan—ALB—Vitamin B12 Metabolism—SOD1—atherosclerosis	0.000443	0.00393	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—PLAT—atherosclerosis	0.000442	0.00392	CbGpPWpGaD
Cefotetan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—atherosclerosis	0.000441	0.00391	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VWF—atherosclerosis	0.000425	0.00376	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—APOB—atherosclerosis	0.000415	0.00368	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—MPO—atherosclerosis	0.000411	0.00364	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—APOB—atherosclerosis	0.000408	0.00362	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—LDLR—atherosclerosis	0.000408	0.00362	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ESAM—atherosclerosis	0.000408	0.00361	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—ABCA1—atherosclerosis	0.000404	0.00358	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—SOD2—atherosclerosis	0.000399	0.00353	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—CCL5—atherosclerosis	0.000399	0.00353	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—LPL—atherosclerosis	0.000396	0.00351	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—F7—atherosclerosis	0.000394	0.00349	CbGpPWpGaD
Cefotetan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—atherosclerosis	0.000389	0.00345	CbGpPWpGaD
Cefotetan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—atherosclerosis	0.000385	0.00341	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SCARB1—atherosclerosis	0.000382	0.00338	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—PLG—atherosclerosis	0.000376	0.00333	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000364	0.00322	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—SOD1—atherosclerosis	0.00036	0.00319	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PLAT—atherosclerosis	0.000351	0.00311	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—MTHFR—atherosclerosis	0.000351	0.00311	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000347	0.00307	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—CRP—atherosclerosis	0.000334	0.00296	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—KNG1—atherosclerosis	0.000333	0.00295	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—APOB—atherosclerosis	0.000332	0.00294	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—APOE—atherosclerosis	0.000332	0.00294	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—CAV1—atherosclerosis	0.000329	0.00292	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—APOA1—atherosclerosis	0.000328	0.00291	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—APOE—atherosclerosis	0.000327	0.0029	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—SOD2—atherosclerosis	0.000325	0.00288	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—APOA1—atherosclerosis	0.000323	0.00286	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—PLG—atherosclerosis	0.000322	0.00286	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—ABCA1—atherosclerosis	0.000321	0.00285	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—atherosclerosis	0.000317	0.00281	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000314	0.00279	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—GPX1—atherosclerosis	0.00031	0.00274	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—SOD1—atherosclerosis	0.000309	0.00274	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—F2—atherosclerosis	0.000308	0.00273	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—ICAM1—atherosclerosis	0.000307	0.00272	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PLG—atherosclerosis	0.000307	0.00272	CbGpPWpGaD
Cefotetan—Cefoperazone—ALB—atherosclerosis	0.000306	0.0661	CrCbGaD
Cefotetan—ALB—Selenium Micronutrient Network—PLG—atherosclerosis	0.000299	0.00265	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—atherosclerosis	0.000294	0.00261	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—IGF2—atherosclerosis	0.000294	0.0026	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SOD1—atherosclerosis	0.000286	0.00254	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—MTHFR—atherosclerosis	0.000286	0.00253	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—atherosclerosis	0.00028	0.00248	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—INS—atherosclerosis	0.000279	0.00247	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—CCL2—atherosclerosis	0.000275	0.00244	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CRP—atherosclerosis	0.000272	0.00241	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—APOB—atherosclerosis	0.000264	0.00234	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—APOA1—atherosclerosis	0.000263	0.00233	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SELP—atherosclerosis	0.000261	0.00231	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—F5—atherosclerosis	0.000261	0.00231	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—CD36—atherosclerosis	0.000259	0.00229	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SOD2—atherosclerosis	0.000258	0.00228	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—SERPINE1—atherosclerosis	0.000257	0.00227	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—atherosclerosis	0.000252	0.00223	CbGpPWpGaD
Cefotetan—Cefazolin—ALB—atherosclerosis	0.000252	0.0543	CrCbGaD
Cefotetan—ALB—Folate Metabolism—F2—atherosclerosis	0.000251	0.00222	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—ICAM1—atherosclerosis	0.00025	0.00221	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CLU—atherosclerosis	0.000249	0.00221	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—CD36—atherosclerosis	0.000246	0.00218	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—GPX1—atherosclerosis	0.000246	0.00218	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000239	0.00212	CbGpPWpGaD
Cefotetan—Ceftriaxone—ALB—atherosclerosis	0.000239	0.0515	CrCbGaD
Cefotetan—ALB—Platelet degranulation—PDGFB—atherosclerosis	0.000238	0.00211	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IFNG—atherosclerosis	0.000234	0.00207	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—INS—atherosclerosis	0.000227	0.00201	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—atherosclerosis	0.000227	0.00201	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000227	0.00201	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—APOA1—atherosclerosis	0.000225	0.002	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000225	0.00199	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CCL2—atherosclerosis	0.000224	0.00198	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CRP—atherosclerosis	0.000216	0.00191	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—atherosclerosis	0.000215	0.0019	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—OLR1—atherosclerosis	0.000214	0.0019	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000209	0.00185	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—SERPINE1—atherosclerosis	0.000209	0.00185	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL1B—atherosclerosis	0.000208	0.00185	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—F2—atherosclerosis	0.000199	0.00177	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000198	0.00176	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VWF—atherosclerosis	0.000198	0.00175	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000195	0.00173	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000195	0.00173	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—NFKB1—atherosclerosis	0.000194	0.00172	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000193	0.00171	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IFNG—atherosclerosis	0.00019	0.00168	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—IGF1—atherosclerosis	0.000188	0.00167	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000185	0.00164	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—INS—atherosclerosis	0.000181	0.0016	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—atherosclerosis	0.00018	0.00159	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—SERPINE1—atherosclerosis	0.000179	0.00159	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000178	0.00157	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—atherosclerosis	0.00017	0.00151	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL1B—atherosclerosis	0.00017	0.0015	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SERPINC1—atherosclerosis	0.000169	0.0015	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000166	0.00147	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—NFKB1—atherosclerosis	0.000158	0.0014	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000154	0.00137	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—TNF—atherosclerosis	0.000151	0.00134	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000151	0.00134	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—KNG1—atherosclerosis	0.000148	0.00131	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000147	0.0013	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000145	0.00128	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000145	0.00128	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000145	0.00128	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PLG—atherosclerosis	0.000143	0.00127	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000142	0.00126	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F3—atherosclerosis	0.000142	0.00126	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00014	0.00124	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SOD1—atherosclerosis	0.000137	0.00121	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000135	0.00119	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F5—atherosclerosis	0.000135	0.00119	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SELP—atherosclerosis	0.000135	0.00119	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000133	0.00118	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF2—atherosclerosis	0.00013	0.00115	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000129	0.00114	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CLU—atherosclerosis	0.000128	0.00114	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000127	0.00112	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000126	0.00111	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VEGFA—atherosclerosis	0.000123	0.00109	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—atherosclerosis	0.000123	0.00109	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000122	0.00109	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000122	0.00109	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000122	0.00109	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000122	0.00109	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL6—atherosclerosis	0.000122	0.00108	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000121	0.00107	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—THBD—atherosclerosis	0.000121	0.00107	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000119	0.00106	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	0.000117	0.00104	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—atherosclerosis	0.000117	0.00104	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000117	0.00104	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000115	0.00102	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CD36—atherosclerosis	0.000115	0.00102	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SELE—atherosclerosis	0.000114	0.00101	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TGFB1—atherosclerosis	0.000113	0.001	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000112	0.000992	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000108	0.000955	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—atherosclerosis	0.000108	0.000954	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LDLRAP1—atherosclerosis	0.000107	0.000944	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	0.000106	0.000937	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000104	0.000923	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VWF—atherosclerosis	0.000102	0.000903	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLTP—atherosclerosis	0.0001	0.000888	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	0.0001	0.000886	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL6—atherosclerosis	9.93e-05	0.00088	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	9.78e-05	0.000866	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F7—atherosclerosis	9.72e-05	0.000862	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	9.54e-05	0.000845	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	9.28e-05	0.000822	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	9.22e-05	0.000817	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	9.17e-05	0.000812	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	9.13e-05	0.000809	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	8.95e-05	0.000793	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG8—atherosclerosis	8.68e-05	0.00077	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LTA4H—atherosclerosis	8.68e-05	0.00077	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAT—atherosclerosis	8.67e-05	0.000768	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	8.57e-05	0.00076	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	8.51e-05	0.000754	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	8.36e-05	0.000741	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	8.1e-05	0.000718	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	7.94e-05	0.000703	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	7.89e-05	0.000699	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—KNG1—atherosclerosis	7.61e-05	0.000674	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAUR—atherosclerosis	7.54e-05	0.000668	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.5e-05	0.000665	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLG—atherosclerosis	7.37e-05	0.000653	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	7.22e-05	0.00064	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SOD1—atherosclerosis	7.07e-05	0.000626	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG1—atherosclerosis	6.87e-05	0.000608	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF2—atherosclerosis	6.71e-05	0.000595	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—APOB—atherosclerosis	6.52e-05	0.000577	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FABP4—atherosclerosis	6.45e-05	0.000572	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LCAT—atherosclerosis	6.45e-05	0.000572	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	6.38e-05	0.000565	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA4—atherosclerosis	6.34e-05	0.000561	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP7A1—atherosclerosis	6.22e-05	0.000551	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCG—atherosclerosis	6.05e-05	0.000536	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.93e-05	0.000526	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CD36—atherosclerosis	5.91e-05	0.000524	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.89e-05	0.000522	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP27A1—atherosclerosis	5.75e-05	0.00051	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.66e-05	0.000502	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	5.64e-05	0.0005	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.53e-05	0.00049	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	5.46e-05	0.000484	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALOX15—atherosclerosis	5.45e-05	0.000483	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALOX5AP—atherosclerosis	5.45e-05	0.000483	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA2—atherosclerosis	5.45e-05	0.000483	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLA2G2A—atherosclerosis	5.45e-05	0.000483	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PDGFB—atherosclerosis	5.45e-05	0.000483	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MMP1—atherosclerosis	5.39e-05	0.000477	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG5—atherosclerosis	5.39e-05	0.000477	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.38e-05	0.000477	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LPA—atherosclerosis	5.2e-05	0.000461	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CAV1—atherosclerosis	5.17e-05	0.000458	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	5.17e-05	0.000458	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—APOA1—atherosclerosis	5.15e-05	0.000457	CbGpPWpGaD
Cefotetan—ALB—Metabolism—BGN—atherosclerosis	5.04e-05	0.000446	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	5.01e-05	0.000444	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5e-05	0.000443	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA5—atherosclerosis	4.99e-05	0.000442	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F2—atherosclerosis	4.92e-05	0.000436	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS2—atherosclerosis	4.86e-05	0.000431	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.85e-05	0.000429	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLA2G1B—atherosclerosis	4.8e-05	0.000425	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.76e-05	0.000421	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.75e-05	0.000421	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CG—atherosclerosis	4.71e-05	0.000417	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.7e-05	0.000417	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.69e-05	0.000416	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALOX5—atherosclerosis	4.64e-05	0.000411	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.46e-05	0.000395	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF1—atherosclerosis	4.31e-05	0.000382	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.28e-05	0.00038	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NAMPT—atherosclerosis	4.16e-05	0.000369	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.13e-05	0.000366	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LIPC—atherosclerosis	4.13e-05	0.000366	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOC3—atherosclerosis	4.11e-05	0.000364	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SERPINE1—atherosclerosis	4.09e-05	0.000363	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LDLR—atherosclerosis	4.08e-05	0.000362	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CETP—atherosclerosis	3.99e-05	0.000353	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS3—atherosclerosis	3.91e-05	0.000346	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SCARB1—atherosclerosis	3.82e-05	0.000338	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMGCR—atherosclerosis	3.61e-05	0.00032	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	3.48e-05	0.000309	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.25e-05	0.000288	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCA1—atherosclerosis	3.21e-05	0.000285	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFA—atherosclerosis	2.81e-05	0.000249	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMOX1—atherosclerosis	2.76e-05	0.000244	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MAPK3—atherosclerosis	2.66e-05	0.000236	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOB—atherosclerosis	2.64e-05	0.000234	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB1—atherosclerosis	2.58e-05	0.000229	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTM1—atherosclerosis	2.57e-05	0.000228	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LPL—atherosclerosis	2.52e-05	0.000223	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX1—atherosclerosis	2.46e-05	0.000218	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CD36—atherosclerosis	2.4e-05	0.000212	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTHFR—atherosclerosis	2.27e-05	0.000201	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARA—atherosclerosis	2.23e-05	0.000197	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AGT—atherosclerosis	2.16e-05	0.000191	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOE—atherosclerosis	2.11e-05	0.000187	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CAV1—atherosclerosis	2.09e-05	0.000186	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APOA1—atherosclerosis	2.09e-05	0.000185	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CG—atherosclerosis	1.91e-05	0.000169	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARG—atherosclerosis	1.84e-05	0.000163	CbGpPWpGaD
Cefotetan—ALB—Metabolism—INS—atherosclerosis	1.81e-05	0.00016	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT1—atherosclerosis	1.8e-05	0.000159	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NOS3—atherosclerosis	1.58e-05	0.00014	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGS2—atherosclerosis	1.45e-05	0.000128	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKT1—atherosclerosis	7.28e-06	6.45e-05	CbGpPWpGaD
